Ultra-rapid rollout vaccination with BNT162b2 to reduce SARS-CoV-2 infections in the general population

This study aimed to determine the impact of ultra-rapid rollout vaccination on incidence of SARS-CoV-2 infection. Vaccination with BNT162b2 was provided to 66.9% of eligible residents of the Schwaz district in Tyrol, Austria, within six days per dose (first dose: 11–16 March 2021, second dose: 8–13...

Descripción completa

Detalles Bibliográficos
Autores principales: Tschiderer, Lena, Seekircher, Lisa, Richter, Lukas, von Laer, Dorothee, Lass-Flörl, Cornelia, Forer, Lukas, Schönherr, Sebastian, Krammer, Florian, Embacher-Aichhorn, Sabine, Tilg, Herbert, Weiss, Günter, Allerberger, Franz, Willeit, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639213/
https://www.ncbi.nlm.nih.gov/pubmed/36373097
http://dx.doi.org/10.1016/j.isci.2022.105380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639213/
https://www.ncbi.nlm.nih.gov/pubmed/36373097
http://dx.doi.org/10.1016/j.isci.2022.105380

Ejemplares similares